Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa (Genetically Engineered Human Erythropoietin - Restriction To Packs With Doses Up To 10,000 Iu)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 82455273

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient epoetin alfa (genetically engin eered human erythropoietin - restricted to packs with dosages of up to 10,000 IU). The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It should be noted t

Gt Ref Id - 82455273

Deadline - Jul 31, 2026